How long until Wegovy starts working — what the evidence shows

Appetite suppression is usually the earliest sign Wegovy is working, many people notice reduced hunger within the first one to two weeks at the 0.25mg starting dose.
Visible weight loss on the scales typically begins in weeks two to four, with the rate accelerating as doses increase toward the 2.4mg maintenance level.
The STEP 1 trial showed average weight loss of around 15% over 68 weeks, results build over months, not a single pen.
Individual responses vary; factors including starting weight, diet, activity and dose stage all affect how quickly progress becomes noticeable.

Most people begin to notice Wegovy working within the first two to four weeks, though meaningful weight loss typically becomes visible over months rather than days. The STEP 1 trial, published in the New England Journal of Medicine, followed adults on semaglutide 2.4mg for 68 weeks and recorded an average body-weight reduction of around 15%, with loss accumulating steadily across the full treatment period. That context matters: how long until Wegovy starts working depends partly on what you're measuring. Appetite often shifts first. The scales catch up later. Because Wegovy is a prescription-only medicine, a prescriber assesses your full clinical picture before treatment begins — the timeline they discuss with you is personalised, not generic.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the trial data and clinical guidance tell us about Wegovy's timeline

What STEP 1 actually measured, and why the timeline is longer than most expect

The STEP 1 trial is the clearest window we have into how long it takes Wegovy to work at a population level. Researchers followed 1,961 adults with obesity or overweight and at least one weight-related condition for 68 weeks. At 2.4mg weekly, participants lost an average of around 15% of their body weight, but that figure is the endpoint of a journey, not a quick result. Weight loss in the trial was not linear: the steepest drops came in the middle months, as doses moved through the titration schedule and appetite suppression deepened.

The NHS medicines page for semaglutide confirms the same picture: treatment is gradual, and the full maintenance dose of 2.4mg (or the recently approved 7.2mg option) is only reached after a series of four-weekly increases from the 0.25mg starting point. Expecting dramatic results in week one sets people up for unnecessary disappointment. The starter dose exists almost entirely to let your body adjust, rather than to drive large-scale loss.

There is a useful habit here: weigh yourself on the same day each week, first thing in the morning, before eating. A single weigh-in tells you very little, body weight shifts by a kilo or more day to day from fluid alone. A four-week trend is genuinely informative. If you want a detailed breakdown of how long until you start losing weight on Wegovy, including what realistic early progress looks like across the titration schedule, that page walks through the timeline in full. One minute, once a week, same conditions. That's the signal; the daily noise is not.

The appetite shift comes first, here is what to expect by stage

For most people, the first sign that Wegovy is doing something is a change in hunger rather than a drop on the scales. GLP-1 receptor agonists like semaglutide slow gastric emptying and act on appetite centres in the brain, so a sense of fullness arriving sooner at meals (or simply thinking about food less) often precedes any measurable weight change. If you want to understand how long till Wegovy starts working in terms of these early appetite signals, the changes can happen in the first week or two, even at the lowest dose.

By weeks four to eight, as the dose moves from 0.25mg to 0.5mg and then to 1.0mg, most people on treatment are noticing consistent scale movement. The pace typically picks up again around weeks twelve to sixteen, once the 1.7mg and then 2.4mg doses are reached. If you are curious about what a typical progression looks like week by week, our page on how long before Wegovy starts working covers the early-stage picture in more detail.

Not everyone follows the same curve. Starting weight, metabolic history, how closely diet and activity change alongside treatment, and individual variation in GLP-1 sensitivity all shape the timeline. A prescriber, not a forum post, is the right source for what to expect in your specific case.

When NICE and clinical guidance say to reassess progress

The NICE recommendation for semaglutide (Wegovy), TA875, includes a formal checkpoint: if someone has not lost at least 5% of their starting body weight after six months on the maintenance dose, continuing treatment is reviewed by the prescriber. That six-month threshold is not a failure point, it is a clinical safeguard, built into the guidance precisely because responses vary and ongoing treatment should always be proportionate to benefit.

Six months is also long enough for most people to have spent several months at or near their maintenance dose. The early weeks of dose titration are not the same as being fully established on treatment, and results during that phase should be read accordingly. For a closer look at how long until Wegovy works across the full titration period, that page explains how the dose increases fit into the bigger picture alongside the NICE checkpoint.

For people considering the cost and commitment alongside the clinical timeline, the full Wegovy treatment overview sets out what private treatment involves from consultation through to ongoing clinical review. Pricing context, including what a transparent all-in cost covers, is on our treatments page.

Factors that shape how quickly you see results

Trial averages are useful benchmarks, but they obscure real variation. Several factors consistently affect how fast Wegovy produces visible results in practice. Dietary composition matters: protein adequacy and fibre intake tend to support the appetite effects of the medicine and preserve lean mass during loss, which affects both the speed and quality of the result. Activity level plays a role too, particularly resistance exercise, which helps maintain muscle as overall weight falls.

Dose stage is perhaps the biggest single variable in the short term. Someone at week four on 0.25mg is genuinely at a different therapeutic position than someone who has been on 2.4mg for eight weeks. Comparing their week-four results is not particularly meaningful. The medicine takes time to work not because it is slow, but because the titration schedule is deliberate, side effects, particularly gastrointestinal ones, are substantially reduced by moving through doses gradually.

If you are thinking about starting, or want to understand whether Wegovy is right for your circumstances, our prescribers review every consultation personally. Check your eligibility by visiting our free consultation page, same-day clinical review, no waiting list, and treatment dispatched the next working day once approved.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions